Ambry’s digital CARE Program TM improves patient care by expanding access to carrier screening and non-invasive prenatal testing (NIPT). ALISO VIEJO, Calif.--(BUSINESS WIRE)--Ambry Genetics (Ambry), a ...

IRVINE, CA (November 12, 2004) – AMBRY GENETICS, a leading genetic testing company, announced it has added a new research test to its product line. Ambry Genetics is offering ADRB2 sequencing, ...

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Ambry Genetics, a prominent leader in clinical genomic testing and a subsidiary of REALM IDx, Inc., unveiled at the American Society of Human Genetics (ASHG) ...

Shares of Tempus AI TEM gained 18.4% after it announced an agreement, on Nov. 4, 2024, to acquire Ambry Genetics for $600 million. This acquisition will likely help Tempus revolutionize healthcare by ...

The Ambry CARE Program® brings accurate, personalized breast cancer risk assessments directly into clinical workflows helping direct patients at high risk for breast cancer to seek additional ...

The first data released today are anonymized, aggregated data of 10,000 human genomes (exomes) focused on hereditary breast and ovarian cancer. Ambry Genetics has already identified 10-fold more genes ...

Ambry Genetics Corp., a closely held genetic diagnostics company in Aliso Viejo, just sold for $800 million—maybe more. The Japanese photocopier and printer maker Konica Minolta signed a definitive ...

TOKYO (Reuters) - Konica Minolta Inc <4902.T> said it was purchasing U.S. diagnostics company Ambry Genetics in a deal valued at up to $1 billion - an acquisition that marks a strategic shift for the ...

Firms may expand microdroplet-based applications to include Methyl-Seq and Ultra-Deep Resequencing. Ambry Genetics and RainDance Technologies are partnering to offer diagnostics and genomics services ...